Roles of levo-tetrahydropalmatine in modulating methamphetamine reward behavior

Physiology and Behavior

Volumn 118, Issue , 2013, Pages 195-200

  Su, Hong Liang ^a   Zhu, Jie ^a   Chen, Yan Jiong ^a   Zhao, Na ^a   Han, Wei ^a   Dang, Yong Hui ^a   Xu, Ming ^b   Chen, Teng ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Acquisition; Conditioned place preference; Extinction; L Tetrahydropalmatine; Methamphetamine; Reinstatement

Indexed keywords

ALKALOID DERIVATIVE; LEVO TETRAHYDROPALMATINE; METHAMPHETAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVERSIVE BEHAVIOR; COGNITION; CONTROLLED STUDY; DRUG INHIBITION; MALE; METHAMPHETAMINE DEPENDENCE; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; REINFORCEMENT; REINSTATEMENT; REWARD; TASK PERFORMANCE;

EID: 84879514217     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2013.05.034     Document Type: Article

References (56)

1. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2010, 35:217-238.
2. Robinson T.E., Berridge K.C. Addiction. Annu Rev Psychol 2003, 54:25-53.
3. Hyman S.E., Malenka R.C., Nestler E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 2006, 29:565-598.
4. Kalivas P.W., O'Brien C. Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology 2008, 33:166-180.
5. Kalivas P.W., Volkow N.D. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 2005, 162:1403-1413.
6. Koob G.F., Ahmed S.H., Boutrel B., Chen S.A., Kenny P.J., Markou A., et al. Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev 2004, 27:739-749.
7. Robinson T.E., Berridge K.C. The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 2000, 95:S91-S117.
8. Ren Z., Sun W.L., Jiao H., Zhang D., Kong H., Wang X., et al. Dopamine D1 and NMDA receptors and ERK mediate neuronal morphological changes induced by repeated cocaine administration. Neuroscience 2010, 168:48-60.
9. Robinson T.E., Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 2004, 47:33-46.
10. Kauer J.A., Malenka R.C. Synaptic plasticity and addiction. Nat Rev Neurosci 2007, 8:844-858.
11. Dackis C., O'Brien C. Neurobiology of addiction: treatment and public policy ramifications. Nat Neurosci 2005, 8:1431-1436.
12. Bardo M.T., Bevins R.A. Conditioned place preference: what does it add to our preclinical understanding of drug reward?. Psychopharmacology 2000, 153:31-43.
13. Tzschentke T.M. Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 2007, 12:227-462.
14. Kelley A.E., Berridge K.C. The neuroscience of natural rewards: relevance to addictive drugs. J Neurosci 2002, 22:3306-3311.
15. Wise R.A. Forebrain substrates of reward and motivation. J Comp Neurol 2005, 493:115-121.
16. Bardo M.T., Bowling S.L., Robinet P.M., Rowlett J.K., Lacy M., Mattingly B.A. Role of D1 and D2 receptors in novelty-maintained place preference. Exp Clin Psychopharmacol 1993, 1:101-109.
17. Chen L., Xu M. Dopamine D1 and D3 receptors are differentially involved in cue-elicited cocaine seeking. J Neurochem 2010, 114:530-541.
18. Sanchez C.J., Bailie T.M., Wu W.R., Li N., Sorg B.A. Manipulation of dopamine d1-like receptor activation in the rat medial prefrontal cortex alters stress- and cocaine-induced reinstatement of conditioned place preference behavior. Neuroscience 2003, 119:497-505.
19. Shippenberg T.S., Herz A. Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of mu- and kappa-opioid agonists. Brain Res 1987, 436:169-172.
20. Hubner C.B., Moreton J.E. Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat. Psychopharmacology 1991, 105:151-156.
21. Rowlett J.K., Platt D.M., Yao W.D., Spealman R.D. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys. J Pharmacol Exp Ther 2007, 321:1135-1143.
22. Kong H., Kuang W., Li S., Xu M. Activation of dopamine D3 receptors inhibits reward-related learning induced by cocaine. Neuroscience 2011, 176:152-161.
23. Zhu J., Chen Y., Zhao N., Cao G., Dang Y., Han W., et al. Distinct roles of dopamine D3 receptors in modulating methamphetamine-induced behavioral sensitization and ultra-structural plasticity in the shell of nucleus accumbens. J Neurosci Res 2012, 90:895-904.
24. Ito R., Robbins T.W., Everitt B.J. Differential control over cocaine-seeking behavior by nucleus accumbens core and shell. Nat Neurosci 2004, 7:389-397.
25. Schultz W. Getting formal with dopamine and reward. Neuron 2002, 36:241-263.
26. Volkow N.D., Fowler J.S., Wang G.J., Baler R., Telang F. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 2009, 56:S3-S8.
27. Wise R.A. Dopamine and reward: the anhedonia hypothesis 30years on. Neurotox Res 2008, 14:169-183.
28. Wise R.A. Dopamine, learning and motivation. Nat Rev Neurosci 2004, 5:483-494.
29. Ding G.S. Important Chinese herbal remedies. Clin Ther 1987, 9:345-357.
30. Chu H., Jin G., Friedman E., Zhen X. Recent development in studies of tetrahydroprotoberberines: mechanism in antinociception and drug addiction. Cell Mol Neurobiol 2008, 28:491-499.
31. Guo X., Wang L.M., Liu J., Jin G.Z. Characteristics of tetrahydroprotoberberines on dopamine D1 and D2 receptors in calf striatum. Zhongguo Yao Li Xue Bao 1997, 18:225-230.
32. Hu J.Y., Jin G.Z. Supraspinal D2 receptor involved in antinociception induced by l-tetrahydropalmatine. Zhongguo Yao Li Xue Bao 1999, 20:715-719.
33. Huang K.X., Jin G.Z. The antagonistic effects of tetrahydroprotoberberines on dopamine receptors: electrophysiological studies. Sci China B 1992, 35:688-696.
34. Jin G.Z. (-)-Tetrahydropalmatine and its analogues as new dopamine receptor antagonists. Trends Pharmacol Sci 1987, 8:81-82.
35. Sun B.C., Huang K.X., Jin G.Z. Comparison of effects of tetrahydropalmatine enantiomers on firing activity of dopamine neurons in substantia nigra pars compacta. Zhongguo Yao Li Xue Bao 1992, 13:292-297.
36. Xu S.X., Yu L.P., Han Y.R., Chen Y., Jin G.Z. Effects of tetrahydroprotoberberines on dopamine receptor subtypes in brain. Zhongguo Yao Li Xue Bao 1989, 10:104-110.
37. Zhu X.Z., Zhou Z., Ji X.Q., Gu J., Luo L.G., Wang F.S. l-Tetrahydropalmatine increases leucine enkephalin levels in corpus striatum of rats. Zhongguo Yao Li Xue Bao 1991, 12:104-107.
38. Mantsch J.R., Wisniewski S., Vranjkovic O., Peters C., Becker A., Valentine A., et al. Levo-tetrahydropalmatine attenuates cocaine self-administration under a progressive-ratio schedule and cocaine discrimination in rats. Pharmacol Biochem Behav 2010, 97:310-316.
39. Mantsch J.R., Li S.J., Risinger R., Awad S., Katz E., Baker D.A., et al. Levo-tetrahydropalmatine attenuates cocaine self-administration and cocaine-induced reinstatement in rats. Psychopharmacology 2007, 192:581-591.
40. Wang J.B., Mantsch J.R. l-Tetrahydropalamatine: a potential new medication for the treatment of cocaine addiction. Future Med Chem 2012, 4:177-186.
41. Liu Y.L., Yan L.D., Zhou P.L., Wu C.F., Gong Z.H. Levo-tetrahydropalmatine attenuates oxycodone-induced conditioned place preference in rats. Eur J Pharmacol 2009, 602:321-327.
42. Figueroa-Guzman Y., Mueller C., Vranjkovic O., Wisniewski S., Yang Z., Li S.J., et al. Oral administration of levo-tetrahydropalmatine attenuates reinstatement of extinguished cocaine seeking by cocaine, stress or drug-associated cues in rats. Drug Alcohol Depend 2011, 116:72-79.
43. Xi Z.X., Yang Z., Li S.J., Li X., Dillon C., Peng X.Q., et al. Levo-tetrahydropalmatine inhibits cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats. Neuropharmacology 2007, 53:771-782.
44. Liu Y.L., Liang J.H., Yan L.D., Su R.B., Wu C.F., Gong Z.H. Effects of l-tetrahydropalmatine on locomotor sensitization to oxycodone in mice. Acta Pharmacol Sin 2005, 26:533-538.
45. Yang Z., Shao Y.C., Li S.J., Qi J.L., Zhang M.J., Hao W., et al. Medication of l-tetrahydropalmatine significantly ameliorates opiate craving and increases the abstinence rate in heroin users: a pilot study. Acta Pharmacol Sin 2008, 29:781-788.
46. Zhang J., Zhang L., Jiao H., Zhang Q., Zhang D., Lou D., et al. c-fos facilitates acquisition and extinction of cocaine induced persistent changes. J Neurosci 2006, 26:13287-13296.
47. Kreibich A.S., Blendy J.A. cAMP response element-binding protein is required for stress but not cocaine-induced reinstatement. J Neurosci 2004, 24:6686-6692.
48. Nordquist R.E., Vanderschuren L.J., Jonker A.J., Bergsma M., de Vries T.J., Pennartz C.M., et al. Expression of amphetamine sensitization is associated with recruitment of a reactive neuronal population in the nucleus accumbens core. Psychopharmacology 2008, 198:113-126.
49. Chapman D.E., Hanson G.R., Kesner R.P., Keefe K.A. Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine. J Pharmacol Exp Ther 2001, 296:520-527.
50. Chen Y.J., Liu Y.L., Zhong Q., Yu Y.F., Su H.L., Toque H.A., et al. Tetrahydropalmatine protects against methamphetamine-induced spatial learning and memory impairment in mice. Neurosci Bull 2012, 28:222-232.
51. Xiao L., Tan B., Li Y., Sui N. Involvement of dopamine D1 receptors on the expression of morphine-induced place preference in chicks. Chin J Drug Depend 2004, 13:96-99.
52. Barrett R.L., Appel J.B. Effects of stimulation and blockade of dopamine receptor subtypes on the discriminative stimulus properties of cocaine. Psychopharmacology 1989, 99:13-16.
53. Vanover K.E., Kleven M.S., Woolverton W.L. Blockade of the discriminative stimulus effects of cocaine in rhesus monkeys with the D(1) dopamine antagonists SCH-39166 and A-66359. Behav Pharmacol 1991, 2:151-159.
54. Depoortere R.Y., Li D.H., Lane J.D., Emmett-Oglesby M.W. Parameters of self-administration of cocaine in rats under a progressive-ratio schedule. Pharmacol Biochem Behav 1993, 45:539-548.
55. A binding site. Planta Med 2003, 69:305-309.
56. Lu Z.Z., Wei X., Jin G.Z., Han Q.D. Antagonistic effects of tetrahydroprotoberberine homologues on alpha 1-adrenoceptor. Yao Xue Xue Bao 1996, 31:652-656.